CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,688 | $572.60 | $2.1M | 42,104 |
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −567 | $573.38 | $325K | 41,537 |
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −521 | $574.71 | $299K | 41,016 |
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −143 | $575.26 | $82K | 40,873 |
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $576.33 | $207K | 40,513 |
| 2026-04-23 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 129,288 | ||
| 2026-04-22 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −364 | $575.85 | $210K | 18,996 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −523 | $572.48 | $299K | 49,490 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,644 | $574.06 | $944K | 47,846 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −736 | $574.86 | $423K | 47,110 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,410 | $575.99 | $812K | 45,700 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,707 | $576.98 | $985K | 43,993 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,781 | $578.11 | $1.0M | 42,212 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,099 | $579.08 | $636K | 41,113 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $580.06 | $348K | 40,513 |
| 2026-04-22 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 138,788 | ||
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +7,500 | $146.03 | $1.1M | 48,013 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +2,000 | $146.03 | $292K | 50,013 |
| 2026-04-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −159 | $564.35 | $90K | 49,854 |
Page 118 of 121 · 2,404 trades